Drug Trial Radar · NCT00076388
Iressa Versus Docetaxel (Taxotere)
Last checked: Nov 19, 2026Latest source record: May 13, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,440
Actual
Start
Feb 2004
Primary completion
Mar 2007
Study completion Oct 2007
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jan 23, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effects of ZD1839 or docetaxel in patients with advanced non-small cell lung cancer (NSCLC) that has recurred or progressed after receiving prior treatment with platinum-based chemotherapy.
Conditions
- Non-Small-Cell Lung Carcinoma
Interventions
GefitinibDrug
DocetaxelDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- To compare overall survival between ZD1839 and docetaxel
Locations
162 sites in 25 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Fountain Valley, California
Research Site
Los Angeles, California
Research Site
Santa Rosa, California
Research Site
Stockton, California
Research Site
Colorado Springs, Colorado
Research Site
Norwich, Connecticut
Research Site
Newark, Delaware
Research Site
Boca Raton, Florida
Research Site
Orlando, Florida
Research Site
Macon, Georgia
Research Site
Tucker, Georgia
Research Site
Skokie, Illinois
Research Site
Knoxville, Kentucky
Research Site
Saint Louis Park, Minnesota
Research Site
Great Neck, New York
Research Site
Rochester, New York
Research Site
Syracuse, New York
Research Site
Chapel Hill, North Carolina
Research Site
Charlotte, North Carolina
Research Site
Durham, North Carolina
Research Site
Cleveland, Ohio
Research Site
Portland, Oregon
Research Site
Philadelphia, Pennsylvania
Research Site
Pittsburgh, Pennsylvania
Research Site
Columbia, South Carolina
Research Site
Nashville, Tennessee
Research Site
Austin, Texas
Research Site
Dallas, Texas
Research Site
Houston, Texas
Research Site
Tyler, Texas
Research Site
Salt Lake City, Utah
Research Site
Fairfax, Virginia
Research Site
Seattle, Washington
Research Site
Racine, Wisconsin
Research Site
Buenos Aires, Argentina
Research Site
Córdoba, Argentina
Research site
El Palomar, Argentina
Research Site
Mar del Plata, Argentina
Research Site
Quilmes, Argentina
Showing 40 of 162 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.